Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 886 | 1,263 | 1,772 | 1,118 | 3,676 |
| Cost of Goods | 994 | 1,207 | 1,266 | 1,067 | 1,181 |
| Gross Profit | -108 | 56 | 506 | 51 | 2,495 |
| Operating Expenses | 44,486 | 27,314 | 25,931 | 21,460 | 34,654 |
| Operating Income | -43,600 | -27,051 | -25,159 | -21,342 | -31,978 |
| Other Income | -85 | -230 | 487 | 710 | 760 |
| Pre-tax Income | -43,685 | -27,281 | -24,672 | -20,632 | -31,218 |
| Net Income Continuous | -43,685 | -27,281 | -24,672 | -20,632 | -31,218 |
| Net Income Discontinuous | -6,191 | -10,284 | -13,879 | -12,108 | N/A |
| Net Income | $-49,876 | $-37,565 | $-38,551 | $-32,740 | $-31,218 |
| EPS Basic Total Ops | -1.21 | -0.91 | -0.99 | -1.06 | -1.01 |
| EPS Basic Continuous Ops | -1.06 | -0.66 | -0.64 | -0.67 | -1.01 |
| EPS Basic Discontinuous Ops | -0.15 | -0.25 | -0.36 | -0.39 | N/A |
| EPS Diluted Total Ops | -1.21 | -0.91 | -0.99 | -1.06 | -1.01 |
| EPS Diluted Continuous Ops | -1.06 | -0.66 | -0.64 | -0.67 | -1.01 |
| EPS Diluted Discontinuous Ops | -0.15 | -0.25 | -0.36 | -0.39 | N/A |
| EBITDA(a) | $-22,865 | $-24,825 | $-24,201 | $-20,958 | $-31,663 |